AWH
Aspira Women`s Health Inc
Halal Rating :
Last Price
$0.50
Last updated:
Market Cap
-
7D Change
-21.8%
1 Year Change
-88.73%
Company Overview
Industries
Exchange
Next Earnings Date
Aspira Women's Health Inc. is a biotech company focused on gynecologic disease. The company develops and commercializes diagnostic tests for early detection of gynecologic cancers and other diseases. Their flagship product is OVA1, a blood test designed to assess the risk of ovarian malignancy in women with adnexal masses.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $2.26m | $6.01m | - | $5000.0 | 0.00% | 0.08% |
| June 30, 2024 | $2.42m | $6.83m | - | $10000.0 | 0.00% | 0.15% |
| March 31, 2024 | $2.15m | $6.87m | - | $5000.0 | 0.00% | 0.07% |
Company Impact
Help us evaluate Aspira Women`s Health Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.